Swift Biosciences has defined the leading edge of next-generation sequencing assay technologies that propel genomics, translational, and clinical research. The company’s growing library of unique and patented technologies feeds a full innovation pipeline
Location: United States, Michigan, Ann Arbor
Employees: 11-50
Total raised: $10M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Mercury Fu... | mercuryfun... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.10.2013 | Series B | $7M | - |
| 12.08.2010 | Series A | $3M | - |
Mentions in press and media 11
| Date | Title | Description |
| 07.06.2021 | Swift Biosciences launches Swift 2S™ Turbo v2 for metagenomic research | |
| 17.08.2020 | Swift Biosciences Expands Coronavirus Research with ACE2 Swift Normalase® Amplicon Panel | |
| 05.07.2017 | Term Sheet — Wednesday, July 5 | Welcome back from the holiday weekend. Like many of you, my days off were peppered with a slew of push notifications about the sexual harassment reckoning happening in Startup-land. I felt disgusted by every new accusation. But I also felt ... |
| 25.10.2013 | Roundup: Swift Biosciences Raises $7M Round, Free Wi-fi Now in Downtown Detroit | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Here’s a look at news from around Southeast Michigan’s innovation community: —Ann Arbor-based Swift Biosciences announced this week that it has raised a $7 million Series B ro... |
| 18.10.2013 | Swift Biosciences Raises $7M in Series B Financing | Swift Biosciences, an Ann Arbor, Michigan-based developer of technologies for genomics and personalized medicine, raised $7m in Series B financing. The round was led by Fletcher Spaght Ventures with participation from Renaissance Venture Ca... |
| 18.10.2013 | Swift Biosciences Pulls $7M in Series B Funds | ANN ARBOR, MI, Swift Biosciences has completed a $7 million Series B funding round led by Fletcher Spaght Ventures. >> Click here for more funding data on Swift Biosciences >> To export Swift Biosciences funding data to PDF ... |
| 07.12.2012 | Swift Biosciences Strikes Licensing Deal with Vela Diagnostics | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Ann Arbor, MI-based Swift Biosciences announced this week that it has signed a licensing deal with Vela Operations, the Singapore-based parent company of Vela Diagnostics. The... |
| 12.08.2010 | Molecular diagnostics firm Swift Biosciences gets $3M investment | Swift plans to use the funding to speed up product development and testing, according to a statement from the company. The round was led by Houston-based DFJ Mercury, and included participation from several individual investors. Swift’s CEO... |
| 12.08.2010 | Swift Biosciences lands $3 million investment | Molecular diagnostics startup Swift Biosciences Inc. pulled in a $3 million Series A investment. The Ann Arbor, Michigan-based company is developing molecular biology reagents, which help scientists and doctors conduct genetic tests to iden... |
| 12.08.2010 | Swift Biosciences Raises $3M in Series A Financing | Swift Biosciences Inc., an Ann Arbor, Michigan-based life sciences company that is developing molecular biology reagents for research and diagnostic applications, completed a $3m Series A financing. The round was led by DFJ Mercury, with pa... |
Show more